It is very difficult to determine if AT1R blockers affect the severity of SARS-CoV-2 infection in human epidemiological investigation because the time of human contact with the virus is unknown, even though one can compare the number of COVID-19 cases, with or without AT1R blocker treatment, in the population in a specific area. Here, AGTR1 is linked to COVID-19.